Expression of PGC1α was induced by lncRNA HCP5 through miR-3619-5p, which promoted trans-activation of PGC1α/CEBPB complex on CPT1, enhanced FAO in GC cells, and led to resistance to oxaliplatin and 5-FU [60]. This evidence concerns the gene CPT2 and gastric cancer.